TY - JOUR
AU - Jason B. Gibbons
AU - Jeffrey S. McCullough
AU - Kara Zivin
AU - Zach Y. Brown
AU - Edward C. Norton
A1 - 
AD - Department of Health Policy & Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, US jgibbo13@jhu.edu; Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, MI, US ; Department of Economics, University of Michigan, Ann Arbor, MI, US ; Gibbons, Jason B.,624 N Broadway St.,Baltimore,US,21205,Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health,jgibbo13@jhu.edu
BT - JAMA Psychiatry
C5 - Opioids & Substance Use; Financing & Sustainability; Healthcare Disparities
CP - 12
DB - APA PsycInfo®
DO - 10.1001/jamapsychiatry.2022.3118
IS - 12
JF - JAMA Psychiatry
LA - English
PY - 2022
SN - 2168-622X, 2168-622X
SP - 1173
EP - 1179+
ST - Association between buprenorphine treatment gaps, opioid overdose, and health care spending in US Medicare beneficiaries with opioid use disorder
T1 - Association between buprenorphine treatment gaps, opioid overdose, and health care spending in US Medicare beneficiaries with opioid use disorder
T2 - JAMA Psychiatry
TI - Association between buprenorphine treatment gaps, opioid overdose, and health care spending in US Medicare beneficiaries with opioid use disorder
U1 - Opioids & Substance Use; Financing & Sustainability; Healthcare Disparities
U3 - 10.1001/jamapsychiatry.2022.3118
VL - 79
VO - 2168-622X, 2168-622X
Y1 - 2022
ER -